These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1254 related items for PubMed ID: 9626048

  • 1. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E, Zietz C, Benelli R, Weninger W, Masiello L, Breier G, Tschachler E, Albini A, Stürzl M.
    Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
    Morini M, Benelli R, Giunciuglio D, Carlone S, Arena G, Noonan DM, Albini A.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):267-71. PubMed ID: 10873597
    [Abstract] [Full Text] [Related]

  • 7. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.
    Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B.
    J Clin Invest; 1995 Apr 24; 95(4):1723-34. PubMed ID: 7535796
    [Abstract] [Full Text] [Related]

  • 8. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
    Ensoli B, Markham P, Kao V, Barillari G, Fiorelli V, Gendelman R, Raffeld M, Zon G, Gallo RC.
    J Clin Invest; 1994 Nov 24; 94(5):1736-46. PubMed ID: 7525646
    [Abstract] [Full Text] [Related]

  • 9. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM.
    J Cell Biochem; 2003 May 01; 89(1):133-43. PubMed ID: 12682914
    [Abstract] [Full Text] [Related]

  • 10. Basic fibroblast growth factor as a growth factor for SRV-2-infected simian retroperitoneal fibromatosis cells, an animal model for AIDS related Kaposi's sarcoma.
    Chung CH, Chiang J, Jiang CM, Chen YY, Huang CY, Chen PG, Chen YJ.
    Neoplasma; 2001 May 01; 48(3):192-9. PubMed ID: 11583288
    [Abstract] [Full Text] [Related]

  • 11. Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells.
    Montaldo F, Maffé A, Morini M, Noonan D, Giordano S, Albini A, Prat M.
    J Cell Physiol; 2000 Aug 01; 184(2):246-54. PubMed ID: 10867650
    [Abstract] [Full Text] [Related]

  • 12. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 01; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K.
    J Cell Physiol; 1998 Dec 01; 177(3):439-52. PubMed ID: 9808152
    [Abstract] [Full Text] [Related]

  • 14. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD, Thorpe PE.
    Cancer Res; 2000 Sep 15; 60(18):5117-24. PubMed ID: 11016638
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
    Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S, Palladino C, Leone P, Bugarini R, Malavasi L, Cafaro A, Falchi M, Valdembri D, Rezza G, Bussolino F, Monini P, Ensoli B.
    Nat Med; 2002 Mar 15; 8(3):225-32. PubMed ID: 11875492
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 15; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells.
    Frank S, Stallmeyer B, Kämpfer H, Schaffner C, Pfeilschifter J.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):367-74. PubMed ID: 10024512
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H, Jezequel S, Löhr M, Shaikh S, Davis D, Soker S, Selwood D, Zachary I.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):164-73. PubMed ID: 11322784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.